CUVL · NASDAQ · Medical - Pharmaceuticals

Clinuvel Pharmaceuticals (ADR) (CUVL)

Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.

$5.84
vs last close+0.04 (+0.65%)

No news on record for this listing yet.